Headquartered in Dublin, Ireland, Horizon Pharma (NASDAQ: HZNP) is a biopharmaceutical company whose aim is to improve lives with the recognition, development, acquisition, and commercialization of accessible medicines to meet a variety of patient medical needs. Horizon Pharma now markets … Continue reading →

Given the latest official data on prostate cancer prevalence compiled by the CDC and the GLOBOCAN project, over 1.1 million cases of what is the fourth most common cancer in both sexes combined and the second most common cancer in … Continue reading →

Moxian, a leader in online-to-offline platform, today announced that it has engaged corporate communications firm DreamTeamNetwork (“DTN”). Austin, Texas-based DTN has assisted more than 300 public companies fine tune their corporate communications strategies, which includes investor relations, public relations, and … Continue reading →

Harvard Apparatus achieved considerable buzz this morning in announcing significant results from animal research on its second-generation bioengineered platform. Demonstrating clear evidence of complete esophageal tissue regeneration within two weeks, the study “far exceeded” company – and market, so it … Continue reading →

With recently reported U.S. housing starts markedly higher in September, above one million for the sixth month in a row and beating the estimates of 1.15 million by analysts at Reuters handedly, U.S. Economic Outlook data forecasting 16 percent growth … Continue reading →

Targeting rare, or underserved conditions, where the potential exists for disruptive innovation has long been a successful inside track strategy for the biopharma sector. A person doesn’t have to look any further than the niche market for a drug like … Continue reading →

Back in the late 1990’s, the concept of invisible braces being used as an alternative to typical metal wired braces was a hot topic within the specialized branch of dentistry that deals with correcting crooked teeth and improper bites known … Continue reading →